Skip to main content

3 Result(s)

within Paul L. Feingold Remove this filter

and

  1. Article

    Open Access

    Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma

    Checkpoint inhibitors (CPI) have revolutionized the treatment of metastatic melanoma, but most patients treated with CPI eventually develop progressive disease. Local therapy including surgery, ablation or ste...

    Nicholas D. Klemen, Melinda Wang, Paul L. Feingold… in Journal for ImmunoTherapy of Cancer (2019)

    Download PDF (1251 KB) View Article

  2. Article

    Open Access

    Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma

    Immunotherapeutic treatment strategies including adoptive cell transfer (ACT) for metastatic melanoma are capable of mediating complete and durable responses, as well as partial responses and prolonged disease...

    Nicholas D. Klemen, Paul L. Feingold, Stephanie L. Goff… in Annals of Surgical Oncology (2017)

    Download PDF (605 KB) View Article

  3. No Access

    Article

    Thoracic Surgery in Chronic Granulomatous Disease: a 25-Year Single-Institution Experience

    Chronic granulomatous disease (CGD) is a genetic disorder in which phagocyte dysfunction leads to recurrent infection. Persistent pulmonary infections sometimes require thoracic surgical intervention. We revie...

    Paul L. Feingold, Humair S. Quadri, Seth M. Steinberg… in Journal of Clinical Immunology (2016)